Low-Risk Childhood Hodgkin Lymphoma
Intermediate-Risk Childhood Hodgkin Lymphoma
High-Risk Childhood Hodgkin Lymphoma
Nodular Lymphocyte Predominant Childhood Hodgkin Lymphoma

Low-Risk Childhood Hodgkin Lymphoma

Treatment of low-risk childhood Hodgkin lymphoma may include the following:

• Combination chemotherapy with low- dose radiation therapy to involved areas.
• A clinical trial of combination chemotherapy with or without low-dose radiation therapy to involved areas.

This summary section refers to specific treatments under study in clinical trials, but it may not mention every new treatment being studied. Information about ongoing clinical trials is available from the NCI Web site.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with stage I childhood Hodgkin lymphoma and stage II childhood Hodgkin lymphoma.

Treatment of intermediate-risk childhood Hodgkin lymphoma may include the following:

• Combination chemotherapy with low- dose radiation therapy to involved areas.
• A clinical trial of combination chemotherapy with or without low-dose radiation therapy to involved areas.
• A clinical trial of new combinations of chemotherapy before low-dose radiation therapy to involved areas.

This summary section refers to specific treatments under study in clinical trials, but it may not mention every new treatment being studied. Information about ongoing clinical trials is available from the NCI Web site.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with stage I childhood Hodgkin lymphoma, stage II childhood Hodgkin lymphoma, stage III childhood Hodgkin lymphoma and stage IV childhood Hodgkin lymphoma.

Treatment of high-risk childhood Hodgkin lymphoma may include intensive or high-dose combination chemotherapy with low- dose radiation therapy to involved areas.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with stage III childhood Hodgkin lymphoma and stage IV childhood Hodgkin lymphoma.

Treatment of nodular lymphocyte predominant childhood Hodgkin lymphoma may include the following:

• Combination chemotherapy with low- dose radiation therapy to involved areas.
• Combination chemotherapy.
• Surgery.
• A clinical trial of surgery to remove a single lymph node.

This summary section refers to specific treatments under study in clinical trials, but it may not mention every new treatment being studied. Information about ongoing clinical trials is available from the NCI Web site

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with childhood nodular lymphocyte predominant Hodgkin lymphoma.

Back to Top

< Previous Section  |  Next Section >